Company Analysis

Verrica Pharmaceuticals Inc. (VRCA)

Nasdaq: VRCA · Pharmaceutical Preparations · West Chester, PA · filing with the SEC since 2015
Grade4.4
◀ Past 4.2● Present 4.1▶ Future 5.2
4 est.

Who runs Verrica Pharmaceuticals Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Rieger Jayson
CEO and President. First filing Nov 2024, latest Aug 18, 2026, 3 filings in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
22 people on the record since 2018
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Rieger JaysonCEO and PresidentNov 2024Aug 18, 2026none
Kirby John J.Interim CFONov 2024Aug 18, 2026none
Zawitz DavidChief Operating OfficerDec 2024Aug 18, 2026none
Rosenberg Noah L.CMOMar 2025Aug 18, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Corcoran GavindirectorApr 2025Jun 9, 2026none
Eichenfield LawrencedirectorAug 2020Jun 9, 2026none
Nguyen DiemdirectorJun 2020Jun 9, 2026none
Prygocki Mark A SrdirectorJun 2018Jun 9, 2026none
Frantzreb CharlesdirectorDec 2025Dec 30, 2025none
Manning Paul BdirectorJun 2018Nov 25, 2025none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Bkb Growth Investments, LLC10% ownerJan 2026Feb 2, 2026none
Caligan Partners LPotherDec 2025Dec 30, 2025none
Johnson David EdwardotherDec 2025Dec 30, 2025none
Earlier names on the record16, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton VRCA · research, not advice